Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2026-01-10 @ 2:25 PM
Study NCT ID:
NCT01704703
Status:
COMPLETED
Last Update Posted:
2017-08-01
First Post:
2012-09-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques
Sponsor:
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-10
Start Date Type:
None
Primary Completion Date:
2016-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-07
Completion Date Type:
ACTUAL
First Submit Date:
2012-09-27
First Submit QC Date:
None
Study First Post Date:
2012-10-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-31
Last Update Post Date:
2017-08-01
Last Update Post Date Type:
ACTUAL